CrushSCI.com
126.4Average days
125Median days
24Fastest days
286Longest days
2162025 publications

Paper Review Records

All Paper Review Records

30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

169 days

Validity and Reliability of a Thai Version of the Paediatric Haemophilia Activities List

Authors
Saran Simiwanich; Suttirat Timdang; Wannika Nuanta; Ruamporn Pinijpong; Bunchoo Pongtanakul; Ratcharin KongkasuwanShow moreShow less
Affiliations
1. Golden Jubilee Medical Center Mahidol University Salaya Thailand; 2. Department of Rehabilitation Medicine Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand; 3. Department of Pediatrics Faculty of Medicine Siriraj Hospital Mahidol University Bangkok ThailandShow moreShow less
Source PDF DOI Publisher page
199 days

Clinical Determinants of von Willebrand Factor Antigen, Activity, and Factor VIII Levels in Transfusion‐Dependent Beta‐Thalassemia

Authors
Shayan Bordbar; Mehran Karimi; Amin Shahsavani; Asghar Bazrafshan; Maral Mokhtari; Sezaneh Haghpanah; Omid Reza Zekavat; Mohammadreza BordbarShow moreShow less
Affiliations
1. Medical School Shiraz University of Medical Sciences Shiraz Iran; 2. Hematology‐Oncology Clinic American Hospital Dubai Dubai UAE; 3. Hematology Research Center Shiraz University of Medical Sciences Shiraz Iran; 4. Dastgheib Hospital, Shiraz University of Medical Sciences Shiraz Iran; 5. Pathology Department Shiraz University of Medical Sciences Shiraz IranShow moreShow less
Source PDF DOI Publisher page
98 days

Development of Haemophilia Specialist Nurses and Current Status Survey of Nursing Practice in China

Authors
Wenjing Zhang; Chunrong Chen; Yan Cheng; Lingling Chen; Zhuqin Liu; Xiaohui Yang; Li Zhang; Wenqi Peng; Ning Ding; Jing Sun; Shujie Wang; Yunhai Fang; Man‐Chiu Poon; Kuixing LiShow moreShow less
Affiliations
1. Department of Haematology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China; 2. Department of Nursing Fujian University Union Hospital Fuzhou China; 3. Shandong Blood Center Shandong Hemophilia Treatment Center Jinan China; 4. State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Tianjin Key Laboratory of Gene Therapy For Blood Diseases Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin China; 5. Department of Hematology Nanfang Hospital Guangzhou China; 6. The First Affiliated Hospital of the University of Science and Technology of China & Anhui Provincial Hospital Hefei Anhui China; 7. Children's Hospital of Chongqing Medical University Chongqing China; 8. Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou China; 9. Departments of Medicine, Paediatrics and Oncology, Cumming School of Medicine University of Calgary Calgary Alberta CanadaShow moreShow less
Source PDF DOI Publisher page
185 days

Impact of the Lebanese Crisis on the Treatment of Patients With Haemophilia and von Willebrand Disease

Authors
Nicole Charbel; Sacha El Khoury; Khaled Baroudi; Mohammad Hassan Hodroj; Adlette Inati; Solange Sakr; Cesar Haddad; Hanady Samaha; Ali Taher; Peter NounShow moreShow less
Affiliations
1. Division of Hematology‐Oncology Department of Internal Medicine American University of Beirut Beirut Lebanon; 2. University of Balamand Faculty of Medicine and Medical Sciences Al‐Koura Lebanon; 3. Lebanese Society for Haemophilia Beirut Lebanon; 4. Faculty of Medicine Saint George University of Beirut Beirut LebanonShow moreShow less
Source PDF DOI Publisher page
56 days

Diagnostic and Treatment Availability of von Willebrand Disease Within Europe: Insights From a European Association for Hemophilia and Allied Disorders (EAHAD) Survey

Authors
Omid Seidizadeh; Ana Boban; Susie Shapiro; Riitta Lassila; Sophie Susen; Hamideh Yadegari; Laura Quintas Lorenzo; James S. O'Donnell; Giancarlo Castaman; Jeroen Eikenboom; EAHAD von Willebrand Disease Working GroupShow moreShow less
Affiliations
1. Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Milan Italy; 2. Department of Internal Medicine, Haemophilia Center University Hospital Centar Zagreb, University of Zagreb Medical School Zagreb Croatia; 3. Oxford Haemophilia and Thrombosis Centre Oxford University Hospitals Oxford Oxfordshire UK; 4. Coagulation Disorders Unit Helsinki University Hospital and University of Helsinki Helsinki Finland; 5. Department of Hemostasis and Transfusion, Centre Hospitalier Universitaire Lille, Institut Pasteur de Lille, INSERM, University of Lille Lille France; 6. Institute of Experimental Haematology and Transfusion Medicine, Medical Faculty University of Bonn Bonn Germany; 7. European Haemophilia Consortium Brussels Belgium; 8. Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences Royal College of Surgeons in Ireland (RCSI) Dublin Ireland; 9. Center For Bleeding Disorders and Coagulation, Department of Heart, Lungs, and Vessels Careggi University Hospital Florence Italy; 10. Department of Internal Medicine, Division of Thrombosis and Hemostasis Leiden University Medical Center Leiden the NetherlandsShow moreShow less
Source PDF DOI Publisher page
58 days

Socio‑Economic and Education Profile of Children With Haemophilia A Receiving Prophylaxis and Their Families: Results From a Brazilian Cohort

Authors
Patrícia Santos Resende Cardoso; Márcio Antônio Portugal Santana; Brisa Yuan Renó; Suely Meireles RezendeShow moreShow less
Affiliations
1. Hematology and Oncology Unit University Hospital, Universidade Federal De Minas Gerais Belo Horizonte Minas Gerais Brazil; 2. HEMOMINAS Foundation Belo Horizonte Minas Gerais Brazil; 3. Medical undergraduate, Faculty of Medicine Universidade Federal de Minas Gerais Belo Horizonte Minas Gerais Brazil; 4. Department of Internal Medicine, Faculty of Medicine Universidade Federal de Minas Gerais Belo Horizonte Minas Gerais BrazilShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does HAEMOPHILIA take to review a manuscript?

As of 2026-11-17, CrushSCI has 30 complete review records for HAEMOPHILIA. The fastest paper went from submission to acceptance in 24 days (UK Infected Blood Inquiry–An Historical Appraisal, received 2026-04-03, accepted 2026-04-27); the slowest took 286 days. The average is 126.4 days and the median is 125 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.